SLU7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.002400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.384200E-01
Normal-vs-Stage2
4.394800E-01
Normal-vs-Stage3
8.368400E-02
Normal-vs-Stage4
9.358600E-01
Stage1-vs-Stage2
1.655220E-01
Stage1-vs-Stage3
2.867700E-02
Stage1-vs-Stage4
9.338800E-01
Stage2-vs-Stage3
1.262230E-01
Stage2-vs-Stage4
3.073200E-01
Stage3-vs-Stage4
1.147590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.426600E-01
Normal-vs-AfricanAmerican
7.142800E-01
Normal-vs-Asian
7.294200E-01
Caucasian-vs-AfricanAmerican
6.998800E-01
Caucasian-vs-Asian
6.636400E-01
AfricanAmerican-vs-Asian
9.750400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.092200E-01
Normal-vs-Female
4.958800E-01
Male-vs-Female
9.480200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.556200E-01
Normal-vs-Age(41-60Yrs)
9.802600E-01
Normal-vs-Age(61-80Yrs)
3.141400E-01
Normal-vs-Age(81-100Yrs)
2.056600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.297800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.516000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.473400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.435700E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.225700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.712200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.450800E-01
Normal-vs-Daily Drinker
2.604000E-01
Normal-vs-Weekly Drinker
1.845610E-01
Normal-vs-Occasional Drinker
9.874600E-01
Normal-vs-Social Drinker
8.168200E-01
Non Drinker-vs-Daily Drinker
9.055800E-01
Non Drinker-vs-Weekly Drinker
7.564600E-01
Non Drinker-vs-Occasional Drinker
3.406500E-02
Non Drinker-vs-Social Drinker
9.560500E-02
Daily Drinker-vs-Weekly Drinker
6.862600E-01
Daily Drinker-vs-Occasional Drinker
5.552400E-02
Daily Drinker-vs-Social Drinker
1.314580E-01
Weekly Drinker-vs-Occasional Drinker
4.499700E-02
Weekly Drinker-vs-Social Drinker
9.113900E-02
Occasional Drinker-vs-Social Drinker
7.164200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.456400E-02
Normal-vs-Grade 2
2.625800E-02
Normal-vs-Grade 3
1.514170E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.251000E-01
Grade 1-vs-Grade 3
5.048800E-01
Grade 1-vs-Grade 4
9.456400E-02
Grade 2-vs-Grade 3
7.569400E-01
Grade 2-vs-Grade 4
2.625800E-02
Grade 3-vs-Grade 4
1.514170E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.071200E-01
Normal-vs-NonDiabetic
4.890800E-01
Diabetic-vs-NonDiabetic
2.795200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.085200E-01
Normal-vs-NoPancreatitis
4.596800E-01
Pancreatitis-vs-NoPancreatitis
6.163800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.456200E-01
Normal-vs-N1
4.251000E-01
N0-vs-N1
3.044200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.620800E-01
Normal-vs-TP53-NonMutant
8.334600E-01
TP53-Mutant-vs-TP53-NonMutant
7.862400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
